Welcome to LookChem.com Sign In|Join Free

CAS

  • or

2530-50-9

Post Buying Request

2530-50-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2530-50-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 2530-50-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,5,3 and 0 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 2530-50:
(6*2)+(5*5)+(4*3)+(3*0)+(2*5)+(1*0)=59
59 % 10 = 9
So 2530-50-9 is a valid CAS Registry Number.

2530-50-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-phosphonooctylphosphonic acid

1.2 Other means of identification

Product number -
Other names Octylidenebisphosphonic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2530-50-9 SDS

2530-50-9Upstream product

2530-50-9Downstream Products

2530-50-9Relevant articles and documents

Bisphosphonates as inhibitors of acid sphingomyelinase

-

Page/Page column 8-10, (2011/04/14)

The present invention refers to bisphosphonate and phosphonate/phosphate compounds of Formulae I and II and its use as inhibitors of aSMase enzyme activity.

Bisphosphonates derived from fatty acids are potent inhibitors of Trypanosoma cruzi farnesyl pyrophosphate synthase

Szajnman, Sergio H.,Montalvetti, Andrea,Wang, Youhong,Docampo, Roberto,Rodriguez, Juan B.

, p. 3231 - 3235 (2007/10/03)

Studies on the mode of action of a series of bisphosphonates derived from fatty acids, which had previously proved to be potent inhibitors against Trypanosoma cruzi proliferation in in vitro assays, have been performed. Some of these drugs proved to be potent inhibitors against the intracellular form of the parasite, exhibiting IC50 values at the low micromolar level. As bisphosphonates are FDA clinically approved for treatment of bone resorption disorders, their potential innocuousness makes them good candidates to control tropical diseases.

Oral compositions

-

, (2008/06/13)

Oral compositions providing antitartar and antigingivitis benefits containing an antitartar agent and a stannous salt.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2530-50-9